Does Epigenetic Therapy With Panobinostat Reduce CRPC Bicalutamide Resistance?

Press/Media

Period	11 Dec 2018

Media coverage

Title	Does Epigenetic Therapy With Panobinostat Reduce CRPC Bicalutamide Resistance?
Media name/outlet	Cancer Therapy Advisor
Country/Territory	United States
Date	11/12/18
URL	https://www.cancertherapyadvisor.com/panobinostat-prostate-cancer-crpc-epigenetic-therapy-bicalutamide-resistance-risk/article/820208/
Persons	Anna Ferrari